You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

epcoritamab

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial (Epcoritamab)

Available
  • Lymphoma
  • Epcoritamab
  • (no location specified)
Jan 13, 2023

Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

Not yet recruiting
  • Follicular Lymphoma
  • Low Grade Non-Hodgkin's Lymphoma, Adult
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Jan 20, 2023

Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma Trial in Japan (epcoritamab

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +5 more
  • epcoritamab (monotherapy)
  • +5 more
  • Chuo Ku, Japan
  • +19 more
Jul 19, 2022

CLL/SLL Trial in Worldwide (Epcoritamab, Venetoclax)

Not yet recruiting
  • CLL/SLL
  • Antwerpen, Belgium
  • +23 more
Mar 28, 2023

B-Cell Non-Hodgkin Lymphoma Trial in China (Epcoritamab, Cyclophosphamide, Rituximab)

Recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • Epcoritamab
  • +6 more
  • Beijing, Beijing, China
  • +20 more
May 31, 2022

DLBCL, Follicular Lymphoma Trial in Worldwide (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone, rituximab

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone
  • +7 more
  • Birmingham, Alabama
  • +61 more
Apr 13, 2022

DLBCL, Follicular Lymphoma Trial in United States (Epcoritamab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Follicular Lymphoma
  • Epcoritamab
  • Fountain Valley, California
  • +38 more
Jul 27, 2022

Non Hodgkin Lymphoma Trial in Worldwide (Epcoritamab)

Recruiting
  • Non Hodgkin Lymphoma
  • Epcoritamab
  • Palo Alto, California
  • +44 more
Aug 12, 2022

Non-Hodgkin Lymphoma Trial in Worldwide (Epcoritamab, Lenalidomide, Ibrutinib)

Recruiting
  • Non-Hodgkin Lymphoma
  • Epcoritamab
  • +7 more
  • Tucson, Arizona
  • +83 more
Aug 12, 2022

Diffuse Large B-cell Lymphoma Trial in Worldwide (Epcoritamab, Investigator's Choice Chemotherapy)

Recruiting
  • Diffuse Large B-cell Lymphoma
  • Epcoritamab
  • Investigator's Choice Chemotherapy
  • Irvine, California
  • +233 more
Aug 16, 2022

DLBCL Trial in Worldwide (Epcoritamab, Cyclophosphamide, Rituximab)

Recruiting
  • Diffuse Large B-Cell Lymphoma
  • Epcoritamab
  • +5 more
  • Birmingham, Alabama
  • +376 more
Jan 30, 2023

Follicular Lymphoma (FL) Trial in Worldwide (Epcoritamab, Rituximab, Lenalidomide)

Not yet recruiting
  • Follicular Lymphoma (FL)
  • Epcoritamab
  • +2 more
  • Berkeley, California
  • +267 more
Jun 3, 2022